Proposed Policy Topics for statement development by the APhA Policy Committee

Download Proposed Policy Topics  for statement development by the  APhA Policy Committee

Post on 21-Jan-2016

52 views

Category:

Documents

0 download

DESCRIPTION

Proposed Policy Topics for statement development by the APhA Policy Committee. Moderator: Bradley P. Tice, PharmD, MBA, FAPhA Speaker, APhA House of Delegates. For Your Information. Please submit your thoughts on the policy topics throughout the webinar or send them to HOD@aphanet.org - PowerPoint PPT Presentation

TRANSCRIPT

<ul><li><p>Moderator:Bradley P. Tice, PharmD, MBA, FAPhASpeaker, APhA House of Delegates </p></li><li><p>Please submit your thoughts on the policy topics throughout the webinar or send them to HOD@aphanet.orgIf you are using a phone line to listen, please dial 415-655-0062; Access Code: 856-377-400. Be sure to include your Audio PINTo request to speak, click on the raise hand tab and you will be placed in the queue. The comments we take or mention on the webinar may be limited due to time. However, all comments will be provided to the Policy Committee for use in their deliberations.The moderator will clarify issues but will not engage in debate.Remember, be courteous to your colleagues in your communications.</p></li><li><p>To provide an opportunity for member input on policy topics prior to the proposed statement development by the Policy Committee </p><p>To promote the early engagement of Delegates on the development and submission of quality new business items on topics not assigned to the Policy Committee </p><p>To generate Delegate interest in Policy and House-related committees as part of the policy development process </p></li><li><p>Review the purpose of the House of Delegates</p><p>Review the policy development process</p><p>Review 2013 proposed policy topics and gain perspectives on the issues</p><p>Generate interest and solicit names for House Committees</p><p>Webinar scheduled for 90 minutes.10 minutes for intro, 20 minutes per topic, 20 minutes for final comments</p></li><li><p>House of Delegates serves as a legislative body in the development of ASSOCIATION policy. It shall act on such policy recommendations as shall come before it and shall adopt rules or procedures for the conduct of its business. (from APhA Bylaws) Association PolicyAdvocacy ActivitiesExternal CommunicationsAdvisory CommitteesAssociation Activities</p></li><li><p>House of Delegates Policy CommitteesPolicy CommitteePolicy Review Committee Policy Reference CommitteeNew Business Review CommitteeHouse Rules Review Committee</p><p>House of Delegates Election Committees (every other year)Committee on Nominations Committee of Canvassers</p></li><li><p>50 states plus DC, Guam, and Puerto Rico12 National Pharmacy OrganizationsAAPS, AACP, ACA, ACCP, AIHP, AMCP, ASHP, ASCP, ASPL, NCPA, National Pharmaceutical Association, National Pharmacists Association5 Federal Pharmacy GroupsAir Force, Army, Navy, PHS, VAAPhAAcademies: APPM, APRS, ASPBoard of TrusteesFormer PresidentsFormer Speakers</p></li><li><p>Thomas E. Menighan, BS Pharm, MBA, ScD (Hon), FAPhASecretary, APhA House of Delegates APhA Executive Vice President &amp; CEOAPhA Board of Trustees</p><p>Bradley P. Tice, PharmD, MBA, FAPhASpeaker, APhA House of DelegatesAPhA Board of Trustees</p><p>William H. Riffee, PhDSpeaker - Elect, APhA House of Delegates</p></li><li><p>Topic GenerationIdeas obtained from Delegates, Members, State Pharmacy Associations, Committees, Trustees, Staff, and Surveys43 topic submissions received Recommendations by APhA-APPM/APRS/ASP Joint Policy Standing CommitteeBackground on issues and potential direction assembledTopic Prioritization Committee discussed the top 15 topicsFurther discussed top 15, topics combined, and then ranked top 3Refined direction of top 3 by answering key questions</p></li><li><p>What is the problem?Why is it a problem?What are the issues that need to be addressed?</p></li><li><p>1. Expanding Access to Pharmaceuticals</p><p>2. Ensuring Access to Pharmacists Services (Role of payers and providers in Patient Care)</p><p>3. Medication Take Back/Disposal Programs</p></li><li><p>APhA StaffAPhAHouse of Delegates APhAMembersSurveys, OtherAPhA-APPM/APRS/ASPJoint Policy Standing CommitteeAPhAHouse of DelegatesPolicy Committee PROPOSED Policy StatementAPhA-APPM/APRS/ASPJoint Policy Standing CommitteeImplementation IDEAS For Policy StatementsAPhABoard of TrusteesACTIONAPhAHouse of Delegates APhABoard of TrusteesState AssociationsIDEAGACYOU!WebinarIDEAIDEAWebinarADOPTEDPolicy Statements</p></li><li><p>Setting the stageCurrent drug classification systemRx and OTC (some state variances)Role / Involvement of pharmacists is variableAccess by patients to some pharmaceuticals restrictedPractice actsInsuranceAccess to care provider</p></li><li><p>Summary of Key ConceptsFinancial constraints / shortage of primary care physiciansGrowing interest in increasing accessPharmacists have knowledge / skills When pharmacists are more involved in patient care, health outcomes improve and costs go down.FDA is considering a new paradigm of medication useReluctance among the physician community and some consumer groups that the new paradigm will sever the patient-physician relationship.Concern with use of vending machines, that are resulting in patients purchasing prescription and behind-the-counter medications without access to a pharmacist.</p></li><li><p>Potential ScopeSupporting the creation of an OTC+ or Conditions of Safe Use category of drugs which require pharmacist interventionBehind the counter and vending machine distribution of medications (EC)Stress importance of patients having access to beneficial medications and access to pharmacists services </p></li><li><p>What are the issues that a proposed policy statement should address and what are your suggested directions that the Policy Committee should consider in crafting proposed policy language?Overall importance of patient access to pharmacistsOTC+Support opportunities for pharmacists to assume patient care roles, including OTC+Support updating state and federal laws/regulations to require access to pharmacists Need some pilotsWhich prescription medications (or categories), if any, are appropriate for the OTC+ concept?What drug categories should be included; that we support the process, include monitoring and follow-up; could incorporate adherence for chronic disease medications.Opportunity to increase access and decrease costWay to loop people back into the healthcare system (coordination and collaboration)Coordination with payers for payment and quality measuresWay to improve quality ratingsAddress concerns raised by other health professions</p></li><li><p>What are the issues that a proposed policy statement should address and what are your suggested directions that the Policy Committee should consider in crafting proposed policy language?How should vending machine distribution be controlled to ensure patient safety?Are there features that should be included (access to pharmacist?)Are there medications that should not be distributed via this mechanism?</p></li><li><p>What are your thoughts?</p></li><li><p>Potential Scope of Proposed PolicyWhat is preventing pharmacists from performing medication therapy management (MTM) or other patient care services?Are there system issues impacting this?What is preventing payers from incentivizing or encouraging pharmacists to perform MTM or other patient care services?Are there practice issues creating barriers?</p></li><li><p>What Is The Problem? What are the issues that a proposed policy statement should address and what are your suggested directions that the Policy Committee should consider in crafting proposed policy language?Health benefit data (medical and pharmacy) should be connectedlook at pharmacoeconomic and overall healthcare costs.Decisions need to be pursuant to evidence-based dataCMS standards for MTM programs and contracting directly with providers</p></li><li><p>What Is The Problem? What are the issues that a proposed policy statement should address and what are your suggested directions that the Policy Committee should consider in crafting proposed policy language?OthersPrior authorization programs and formulary management policies can create barriers to patient carePayment to pharmacists by insurance and PBMs for medication management/patient care servicesPBM transparencyPharmacy overregulationAccountability of PBMs regarding the MTM benefit administration and the scope of benefitsProvider status recognition and network inclusion</p></li><li><p>What are your thoughts?</p></li><li><p>Potential ScopePharmaceuticals and Personal Care Products in the EnvironmentsLook at 2012 APhA-ASP policyDevelop and implement standardized guidelines for the proper disposal of unused or expired medications that help prevent drug abuse and reduce harm to the environment. (Source: APhA-ASP 2012.3 Proper Medication Disposal and Drug Take-Back Programs)Allow pharmacies to take back unused or expired medications, including controlled substances, through a process that minimizes diversion, liability, and financial burden to all stakeholders. (Source: APhA-ASP 2012.3 Proper Medication Disposal and Drug Take-Back Programs)Encourage pharmacists and student pharmacists to serve as a source of information for the public on the proper disposal of unused or expired medications. (Source: APhA-ASP 2012.3 Proper Medication Disposal and Drug Take-Back Programs)</p></li><li><p>2009 Medication Disposal1. APhA encourages appropriate public and private partnerships to accept responsibility for the costs of implementing safe medication disposal programs for consumers. Further, APhA urges DEA to permit the safe disposal of controlled substances by consumers.2. APhA encourages provision of patient appropriate quantities of medication supplies to minimize unused medications and unnecessary medication disposal.(JAPhA NS49(4):493 July/August 2009)</p></li><li><p>What are the issues that a proposed policy statement should address and what are your suggested directions that the Policy Committee should consider in crafting proposed policy language?Uniform disposal guidelines that align requirements for state and federal laws and regulations for pharmacists and patientsDisposal of medications and hazardous pharmaceuticals and materialsSafety in the household; lack of effective and available medication take back systems and programs in the community and through local pharmacies.Disposal guidelines and support for it. Should include public awareness of the issue. Take back guidelines (unit of use vs non-unit of use), liability issues, who should pay for the programsAddress liability in relation to diversion by having policies and procedures, protection of public and the patient aspect of thisAddress pharmacist education on take back programs and environmentPolicies that are driving excess meds in environment (like 90 days supply, auto refills, etc)Re-use of meds returnedCost issuesEase take back program requirements through unit of use packaging</p></li><li><p>2012 Controlled Substances Regulation and Patient CareAPhA encourages the U.S. Department of Justice to collaborate with professional organizations to identify and reduce (a) the burdens on health care providers, (b) the cost of health care delivery, and (c) the barriers to patient care in the establishment and enforcement of controlled substance laws.</p></li><li><p>2006/2003 Unit-of-Use PackagingAPhA encourages the continued development, distribution and use of unit-of-use packaging as the industry standard to enhance patient safety, patient compliance, and efficiencies in drug distribution.</p></li><li><p>What are your thoughts?</p></li><li><p>Continue its review of the current APhA Policy Manual by reviewing those statements last reviewed in 2008 (17 statements) .The 2012-13 APhA Policy Review committee will review any current APhA policy that may be affected by statements/topics proposed by the 2012-13 APhA Policy Committee</p><p>Topics Include:Automation and Technology in Pharmacy PracticeAutomation and Technical AssistanceExperiential EducationResidency ProgramsExpansion and Recognition of Internship, Externship, and ClerkshipsResidencies in Community PharmacyPharmacy Schools' Curriculum and Contemporary Pharmacy NeedsState Boards of Pharmacy/InspectionsNational Framework for Practice RegulationSale of Home-use Diagnostic and Monitoring ProductsPrior AuthorizationRegulatory Compliance/Regulatory BurdenPharmacists' Role in the Development and Implementation of Disease-Based Clinical GuidelinesPharmacists and Ambulatory PatientsPromotion of Pharmaceutical Care</p></li><li><p>Opportunity to share additional thoughts or questionsRemember, all comments will be provided to the Policy Committee for use in their deliberations.You may also send your comments to HOD@aphanet.org</p></li><li><p>Policy Committee MeetingSept 7-9, 2012Webinar on proposed policy statementsJanuary 2013 / February 2013</p><p>2013 APhA House of Delegates Policy Reference Committee Open Hearing</p></li><li><p>New Business opportunity</p><p>Forms available on website:www.pharmacist.com/hod </p><p>For more information,Email: hod@aphanet.org </p></li><li><p>Questions</p></li><li><p>This concludes our webinar.Thank you for your participation and comments.</p><p>Questions / CommentsBradley P. Tice, PharmD, MBA, FAPhASpeaker, APhA House of Delegates Email: HOD@aphanet.org </p><p>Post call in number: 888-809-4012 429-7538</p><p>Introduction: </p><p>I am Brad Tice, the chief clinical officer for PharmMD Solutions, a medication therapy management company in Brentwood, Tennessee, and current Speaker of the APhA House of Delegates. I will serve as your moderator today.</p><p>Other moderators on the call with me are:</p><p>Bill Riffee, Speaker elect and Dean, University of Florida COPMitch Rothholz, APhA Chief Strategy Officer</p><p>*Review the above information for the audience.</p><p>*The goals for todays webinar are to provide you the opportunity to provide input to the APhA House of Delegates Policy Committee on the policy topics assigned to it. Your insight will help shape the direction of the proposed policy that will be considered by the House in March 2013. So we want to hear your thoughts.*Todays webinar has 4 objectives:To review the purpose of the House of Delegates and to discuss how association policy is used in the activities of the association. To review the policy development process and to discuss how this webinar fits into the processTo review the proposed policy topics and allow the APhA House of Delegates and membership an opportunity to provide their perspectives on the issues. To generate interest and solicit names for House committees membership</p><p>The APhA Board of Trustees, at the recommendation of the Academies Joint Policy Standing Committee, has assigned the following topics to the 2012-2013 Policy Committee for policy development. 1. Expanding Access to Pharmaceuticals2. Ensuring Access to Pharmacists Services (Role of payers and providers in Patient Care)3. Medication Take Back/Disposal Programs</p><p>While our time is limited, we want to receive your thoughts on the proposed policy statements and encourage you to submit your comments and questions during the webinar or send your thoughts to the House of Delegates via e-mail to HOD@aphanet.org. We will specifically ask for questions and open the dialogue at the end of the introduction of each policy topic and at the end of the session. All comments will be shared with the Policy Committee for consideration during its deliberations. </p><p>The webinar has been scheduled for 90 minutes.10 minutes for intro and background information.Each topic has been allocated 20 minutes20 minutes has been reserved at the end for additional comments</p><p>*For introductions, lets review the Purpose of the APhA House of Delegates. The APhA Bylaws is the Associations principle governance document. It outlines the purpose of the Association, its membership, officers and Board, and the House of Delegates. </p><p>The House of Delegates is the official...</p></li></ul>

Recommended

View more >